Version 2.66

19186-6Cancer Ag 15-3 [Units/volume] in Pleural fluidActive

Cancer Ag 15-3
Plr fld

Additional Names

Short Name
Cancer Ag15-3 Plr-aCnc
Display Name Beta
Cancer Ag 15-3 Qn (Pleur fld)
Consumer Name Alpha
Cancer Ag 15-3, Pleural Fluid

Part Descriptions

LP15461-4   Cancer Ag 15-3
CA 15-3 is a tumor marker for breast cancer. It is derived from MUC1. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, CA 15-3

LP15461-4   Cancer Ag 15-3
Cancer antigen 15-3 (CA 15-3) is a mucin molecule and blood tumor marker used to gauge the response to treatment of invasive breast cancer. CA 15-3 is encoded by the MUC1 gene and is a transmembrane glycoprotein. CA 15-3 may contribute to the growth of breast tumors by preventing tumor cell cytolysis by cytotoxic T-cells or lymphokine-activated cells. It may also block the proliferation of T-cells by causing apoptosis. In addition, CA 15-3 has been found to be expressed over the entire cell in malignant breast tissue while normal breast tissue expresses CA 15-3 only on the apical side of the glanudular epithelial cells. The presence of CA 15-3 is not unique to patients with breast cancer, but can also be found in patients with lung, colorectal, ovarian, and pancreatic cancers. Patients with primary tumors tend to have lower levels of CA 15-3, though the average concentration and percentage of patients goes up as the tumor stage or size of the tumor increases. While only a small number of recurrences of local or regional tumors result in an increased CA 15-3 level, over 70% of patients with remote metastasis have much higher CA 15-3 levels. [PMID: 10505206] Source: Regenstrief LOINC

Basic Attributes

First Released
Version 1.0l
Last Updated
Version 2.66
Order vs. Observation

Language Variants Get Info

zh-CNChinese (China)
癌抗原 15-3:任意型浓度:时间点:胸膜液:定量型:
nl-NLDutch (Netherlands)
kanker Ag 15-3:eenheid/volume:moment:pleuravocht:kwantitatief:
et-EEEstonian (Estonia)
Kasvajaantigeen CA 15-3:Acnc:Pt:PlrF:Qn:
fr-BEFrench (Belgium)
Ag carbohydraté 15-3:Concentration arbitraire:Temps ponctuel:Liquide pleural:Quantitatif:
fr-CAFrench (Canada)
Ag carbohydraté 15-3:Concentration arbitraire:Temps ponctuel:Liquide pleural:Quantitatif:
fr-FRFrench (France)
Cancer Ag 15-3:ACnc:Pt:Plr fld:Qn:
de-ATGerman (Austria)
CA 15-3 /PP
de-DEGerman (Germany)
Cancer Ag 15-3:AKnz:Pkt:Plr Fl:Qn:
it-ITItalian (Italy)
Cancro, Ag 15-3:ACnc:Pt:Liquido pleurico:Qn:
ko-KRKorean (Korea, Republic of)
암 항원 15-3:임의농도:검사시점:흉막액:정량:
pt-BRPortuguese (Brazil)
Câncer Ag 15-3:ACnc:Pt:LiqPleur:Qn:
ru-RURussian (Russian Federation)
Раковый Аг 15-3:ПроизвКонц:ТчкВрм:Плевр ждк:Колич:
es-ARSpanish (Argentina)
antígeno cáncer 15-3:concentración arbitraria:punto en el tiempo:líquido pleural:cuantitativo:
es-ESSpanish (Spain)
Antígeno CA 15-3:Concentración arbitraria:Punto temporal:Líquido pleural:Qn:
tr-TRTurkish (Turkey)
Kanser Ag 15-3:SçKons:Zmlı:Plvr sv:Kant:

Example Units

Unit Source
[arb'U] Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info